Correlation Between Shenzhen Centralcon and Maccura Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shenzhen Centralcon and Maccura Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shenzhen Centralcon and Maccura Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shenzhen Centralcon Investment and Maccura Biotechnology Co, you can compare the effects of market volatilities on Shenzhen Centralcon and Maccura Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shenzhen Centralcon with a short position of Maccura Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shenzhen Centralcon and Maccura Biotechnology.

Diversification Opportunities for Shenzhen Centralcon and Maccura Biotechnology

0.89
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Shenzhen and Maccura is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Shenzhen Centralcon Investment and Maccura Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maccura Biotechnology and Shenzhen Centralcon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shenzhen Centralcon Investment are associated (or correlated) with Maccura Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maccura Biotechnology has no effect on the direction of Shenzhen Centralcon i.e., Shenzhen Centralcon and Maccura Biotechnology go up and down completely randomly.

Pair Corralation between Shenzhen Centralcon and Maccura Biotechnology

Assuming the 90 days trading horizon Shenzhen Centralcon Investment is expected to generate 1.41 times more return on investment than Maccura Biotechnology. However, Shenzhen Centralcon is 1.41 times more volatile than Maccura Biotechnology Co. It trades about 0.18 of its potential returns per unit of risk. Maccura Biotechnology Co is currently generating about -0.13 per unit of risk. If you would invest  528.00  in Shenzhen Centralcon Investment on September 13, 2024 and sell it today you would earn a total of  53.00  from holding Shenzhen Centralcon Investment or generate 10.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Shenzhen Centralcon Investment  vs.  Maccura Biotechnology Co

 Performance 
       Timeline  
Shenzhen Centralcon 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Shenzhen Centralcon Investment are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shenzhen Centralcon sustained solid returns over the last few months and may actually be approaching a breakup point.
Maccura Biotechnology 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Maccura Biotechnology Co are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Maccura Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.

Shenzhen Centralcon and Maccura Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shenzhen Centralcon and Maccura Biotechnology

The main advantage of trading using opposite Shenzhen Centralcon and Maccura Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shenzhen Centralcon position performs unexpectedly, Maccura Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maccura Biotechnology will offset losses from the drop in Maccura Biotechnology's long position.
The idea behind Shenzhen Centralcon Investment and Maccura Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Stocks Directory
Find actively traded stocks across global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Commodity Directory
Find actively traded commodities issued by global exchanges